BioImagene Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 50

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $100M

  • Investors
  • 1

BioImagene General Information

Description

Provider of digital pathology solutions for clinical diagnostics and drug discovery applications. The company develops and distributes integrated hardware and software systems to acquire, view, share, manage, archive, and analyze tissue images in pathology laboratories. It offers IHC algorithms, such as HER2, ER/PR, and p53 for breast cancer; Ki67 for breast, brain, and prostate cancers; CD138 for multiple myeloma; CD3/CD20 for lymphoma; iSlide input device, a device that allows pathologists to use a microscope interface to manipulate digital images of slides; and iScan Coreo Au digital slide scanners that enable digital pathology applications, such as image analysis, telepathology, remote microscopy, and education.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 134 South De Anza
  • Suite 203
  • San Jose, CA 95129
  • United States
+1 (408)
Primary Industry
Diagnostic Equipment
Other Industries
Vertical Market Software
Corporate Office
  • 134 South De Anza
  • Suite 203
  • San Jose, CA 95129
  • United States
+1 (408)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioImagene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 23-Aug-2010 $100M Completed Generating Revenue
8. Later Stage VC (Series D1) 31-Dec-2009 Completed Generating Revenue
7. Later Stage VC 16-Oct-2008 Completed Generating Revenue
6. Later Stage VC (Series D) 12-Aug-2008 Completed Generating Revenue
5. Early Stage VC (Series B2) 15-Nov-2004 Completed Startup
4. Early Stage VC (Series B) 12-Oct-2004 Completed Generating Revenue
3. Early Stage VC (Series B1) 10-Sep-2004 Completed Startup
2. Later Stage VC (Series C) Completed
1. Early Stage VC (Series A) Completed
To view BioImagene’s complete valuation and funding history, request access »

BioImagene Patents

BioImagene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100225668-A1 Modes and interfaces for observation, and manipulation of digital images on computer screen in support of pathologist's workflow Active 09-Mar-2009
DE-60016049-T2 Method for the objective determination of the severity of scars Inactive 15-Jan-1999
DE-60016049-D1 Procedure for the objective determination of the severity of scars Inactive 15-Jan-1999 A61B5/441

BioImagene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioImagene Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Artiman Ventures Venture Capital Minority
Ascension Ventures Corporate Venture Capital Minority
Authosis Ventures Venture Capital Minority
Band of Angels Angel Group Minority
Burrill & Co Merchant Banking Firm Minority
You’re viewing 5 of 11 investors. Get the full list »

BioImagene Acquisitions (1)

BioImagene’s most recent deal was a Merger/Acquisition with Scimagix. The deal was made on 15-Nov-2004.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Scimagix 15-Nov-2004 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view BioImagene’s complete acquisitions history, request access »

BioImagene FAQs

  • When was BioImagene founded?

    BioImagene was founded in 2003.

  • Where is BioImagene headquartered?

    BioImagene is headquartered in San Jose, CA.

  • What is the size of BioImagene?

    BioImagene has 50 total employees.

  • What industry is BioImagene in?

    BioImagene’s primary industry is Diagnostic Equipment.

  • Is BioImagene a private or public company?

    BioImagene is a Private company.

  • What is the current valuation of BioImagene?

    The current valuation of BioImagene is .

  • What is BioImagene’s current revenue?

    The current revenue for BioImagene is .

  • How much funding has BioImagene raised over time?

    BioImagene has raised $47.2M.

  • Who are BioImagene’s investors?

    Artiman Ventures, Ascension Ventures, Authosis Ventures, Band of Angels, and Burrill & Co are 5 of 11 investors who have invested in BioImagene.

  • When was BioImagene acquired?

    BioImagene was acquired on 23-Aug-2010.

  • Who acquired BioImagene?

    BioImagene was acquired by Ventana Medical Systems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process